Suppr超能文献

免疫球蛋白纯化方法及其对抗原特异性抗体质量和产量影响的评估。

Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodies.

作者信息

Bergmann-Leitner Elke S, Mease Ryan M, Duncan Elizabeth H, Khan Farhat, Waitumbi John, Angov Evelina

机构信息

US Military Malaria Vaccine Program, Division of Malaria Vaccine Development, WRAIR, Silver Spring, MD, USA.

出版信息

Malar J. 2008 Jul 14;7:129. doi: 10.1186/1475-2875-7-129.

Abstract

BACKGROUND

Antibodies are the main effectors against malaria blood-stage parasites. Evaluation of functional activities in immune sera from Phase 2a/b vaccine trials may provide invaluable information in the search for immune correlates of protection. However, the presence of anti-malarial-drugs, improper collection/storage conditions or concomitant immune responses against other pathogens can contribute to non-specific anti-parasite activities when the sera/plasma are tested in vitro. Purification of immunoglobulin is a standard approach for reducing such non-specific background activities, but the purification method itself can alter the quality and yield of recovered Ag-specific antibodies.

METHODS

To address this concern, various immunoglobulin (Ig) purification methods (protein G Sepharose, protein A/G Sepharose, polyethylene glycol and caprylic acid-ammonium sulphate precipitation) were evaluated for their impact on the quality, quantity and functional activity of purified rabbit and human Igs. The recovered Igs were analysed for yield and purity by SDS-PAGE, for quality by Ag-specific ELISAs (determining changes in titer, avidity and isotype distribution) and for functional activity by in vitro parasite growth inhibition assay (GIA).

RESULTS

This comparison demonstrated that overall polyethylene glycol purification of human serum/plasma samples and protein G Sepharose purification of rabbit sera are optimal for recovering functional Ag-specific antibodies.

CONCLUSION

Consequently, critical consideration of the purification method is required to avoid selecting non-representative populations of recovered Ig, which could influence interpretations of vaccine efficacy, or affect the search for immune correlates of protection.

摘要

背景

抗体是对抗疟疾血液阶段寄生虫的主要效应物。评估2a/b期疫苗试验免疫血清中的功能活性,可能为寻找保护的免疫相关因素提供宝贵信息。然而,当在体外检测血清/血浆时,抗疟药物的存在、不当的采集/储存条件或针对其他病原体的伴随免疫反应,可能导致非特异性抗寄生虫活性。免疫球蛋白的纯化是减少此类非特异性背景活性的标准方法,但纯化方法本身可能会改变回收的抗原特异性抗体的质量和产量。

方法

为解决这一问题,评估了各种免疫球蛋白(Ig)纯化方法(蛋白G琼脂糖凝胶、蛋白A/G琼脂糖凝胶、聚乙二醇和辛酸-硫酸铵沉淀法)对纯化的兔和人Ig的质量、数量和功能活性的影响。通过SDS-PAGE分析回收的Ig的产量和纯度,通过抗原特异性酶联免疫吸附测定(确定效价、亲和力和同种型分布的变化)分析质量,通过体外寄生虫生长抑制试验(GIA)分析功能活性。

结果

该比较表明,总体而言,人血清/血浆样品的聚乙二醇纯化和兔血清的蛋白G琼脂糖凝胶纯化最适合回收具有功能的抗原特异性抗体。

结论

因此,需要严格考虑纯化方法,以避免选择回收的Ig的非代表性群体,这可能会影响疫苗效力的解释,或影响对保护的免疫相关因素的寻找。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0114/2490700/d9beb4fe5c5d/1475-2875-7-129-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验